Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.
| Brand name | ZOLOFT |
| Generic name | SERTRALINE HYDROCHLORIDE |
| Active ingredient(s) | SERTRALINE HYDROCHLORIDE |
| Distributed by / for | Roerig, Division of Pfizer, Inc., NY NY 10017 |
| NDC | 0049-4910-30 |
| Full product label | Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distributed by Roerig, Division of Pfizer, Inc., NY NY 10017, NDC 0049-4910-30. |
| Recalling firm | Pfizer Inc. |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 68, 214 bottles |
| Recall initiated | 2016-04-28 |
| Report date | 2016-06-01 |
| Recall completed | 2017-07-26 |
| Recall number | D-0857-2016 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New York NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗